Back to Scanner
RAPP
NASDAQRS 1Score 30Rapport Therapeutics, Inc. Common Stock
HealthcareBiotechnology$1.23B1 setup passing
$33.58
0.0% ($0.00)
-20.6% from 52W High
P/E (TTM)
-14.20
Fwd P/E
—
PEG
—
Analyst Upside
+34.0%
EPS Growth
—
Gross Margin
0.0%
ROE
-28.9%
D/E
0.02
Div Yield
0.0%
Avg Volume
219.5K
Price Chart
Key Levels
SMA 200
$23.87
SMA 50
$28.31
Price
$33.58
52W High
$42.29
Target
$45.00
Setup Radar
1/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst